1. Home
  2. CDNA vs CMPS Comparison

CDNA vs CMPS Comparison

Compare CDNA & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$24.08

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$11.34

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
CMPS
Founded
1998
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CDNA
CMPS
Price
$24.08
$11.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$28.00
$25.38
AVG Volume (30 Days)
652.3K
4.3M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
N/A
Revenue Next Year
$11.31
N/A
P/E Ratio
$469.20
N/A
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$2.25
52 Week High
$24.02
$14.76

Technical Indicators

Market Signals
Indicator
CDNA
CMPS
Relative Strength Index (RSI) 65.75 51.12
Support Level $15.80 $5.48
Resistance Level N/A $14.76
Average True Range (ATR) 1.04 0.97
MACD 0.09 -0.30
Stochastic Oscillator 93.00 14.02

Price Performance

Historical Comparison
CDNA
CMPS

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Share on Social Networks: